4.4 Article

A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals

Related references

Note: Only part of the references are listed.
Article Nutrition & Dietetics

Is testing for postprandial hyperinsulinemic hypoglycemia after gastric bypass necessary?

Michele Gasser et al.

CLINICAL NUTRITION (2019)

Article Endocrinology & Metabolism

Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide

Caroline Christfort Ohrstrom et al.

DIABETES OBESITY & METABOLISM (2019)

Article Gastroenterology & Hepatology

Safety and efficacy of pasireotide in dumping syndromeresults from a phase 2, multicentre study

J. Tack et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Surgery

The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery

Clare J. Lee et al.

SURGERY FOR OBESITY AND RELATED DISEASES (2018)

Article Endocrinology & Metabolism

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass

George Tharakan et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)

Article Gastroenterology & Hepatology

A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndrome

E. Deloose et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2014)

Article Endocrinology & Metabolism

High Glycemic Variability Assessed by Continuous Glucose Monitoring After Surgical Treatment of Obesity by Gastric Bypass

Helene Hanaire et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2011)

Article Endocrinology & Metabolism

Metabolic surgery: an evolution through bariatric animal models

H. Ashrafian et al.

OBESITY REVIEWS (2010)